slides · global inventory
Diagram
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 23,622
Current window 14,341-14,370
Pages 788
Rows per page 30
Component
14,341-14,370 of 23,622
11
Uses a phylogenetic tree to justify the use of avian species for antibody production based on evolutionary divergence.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
The slide uses a process-flow header to indicate the current stage in the workflow.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide uses a process-flow comparison to illustrate technological superiority.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The slide uses a process-flow visual at the top to indicate the current stage in the workflow.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide uses a chevron-based process flow to show the antibody discovery pipeline.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations 1 hit
18
The slide uses a process-flow style layout to map inputs (Biological Intelligence) to methods (Computational Tools) and outputs (specific applications).OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations 1 hit
30
The slide uses a layered visual metaphor to represent value drivers, with the top two rows explicitly showing a multiplicative relationship (New Program Starts x Probability of Success x Standard Deal Terms).OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations 1 hit
04
The timeline is split into 'Pre-P3 Health' and 'P3 Health' phases.P3 Health Partners | Investor Conference Presentation Deck | 20 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
05
The slide uses a 'problem-solution' structure, contrasting current systemic failures with the VBC model.P3 Health Partners | Investor Conference Presentation Deck | 20 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
04
Paysafe | Results Presentation Deck | 29 slidesPaysafe | Results Presentation Deck | 29 slides · Paysafe
Conference presentation Investor relations Beat · Interest1 hit
05
The slide uses a before-after structure to illustrate a shift from product-based regional sales to a vertical-based sales structure with centralized enablement.Paysafe | Results Presentation Deck | 29 slides · Paysafe
Conference presentation Investor relations Beat · Before and After1 hit
06
Uses a custom matrix/grid layout to visualize market penetration and expansion strategy.Paysafe | Results Presentation Deck | 29 slides · Paysafe
Conference presentation Investor relations 1 hit
14
Uses a before-after visual structure to show the migration of sub-segments (IES/Enterprise) between parent segments.Paysafe | Results Presentation Deck | 29 slides · Paysafe
Conference presentation Investor relations 1 hit
11
The slide uses a numbered process flow (1-5) overlaid on a visual representation of a solar-powered bus depot.Proterra | Investor Presentation Deck | 28 slides · Proterra
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The slide uses a hub-and-spoke style diagram to show data and power flow between vehicles, the cloud, and the grid.Proterra | Investor Presentation Deck | 28 slides · Proterra
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
The slide uses a grid layout to present headshots, titles, and associated company logos for both the leadership team and the board.Proterra | Investor Presentation Deck | 28 slides · Proterra
Pitch deck Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
25
Uses a simple additive framework to explain competitive advantage.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
30
Uses a nested circle diagram to illustrate market segmentation and penetration.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
31
Includes a table of historical household data (2018-2022) and a revenue bridge calculation.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
33
Uses a nested circle diagram to show market segmentation and penetration.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
07
The slide uses a biological process diagram to explain the mechanism of action for midodrine and droxidopa in the context of autonomic disorders.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide uses a biological process diagram to explain how different drugs (agonists, precursors, reuptake inhibitors) affect sympathetic signaling to blood vessels.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide uses a biological process diagram to explain the drug's mechanism of action.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
11
The slide uses a process flow diagram to show how patients transition from Study 0169 to 0170.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
19
The slide highlights the failure of Study 0169 and the subsequent early termination of Study 0170.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
20
The slide outlines a complex clinical trial structure involving rollovers from Study 0169 and de novo participants, leading into a randomized withdrawal period.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
21
The slide uses a flow diagram to illustrate study design and participant disposition.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
34
The slide outlines a clinical trial program involving three studies (0169, 0170, 0171) with specific eligibility criteria and endpoints for a longitudinal analysis.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
35
The diagram tracks patient enrollment, completion, and reasons for discontinuation at each stage.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
36
The diagram uses a standard CONSORT-style flow chart structure to track patient enrollment, completion, and withdrawal reasons.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit